IP Library › Granted Patent US 12,292,046
Granted Patent B2
US 12,292,046 · App. 17/058,634 · Granted May 6, 2025

Microfluidic filter device and method for dissociation of tissue and cell aggregates and enrichment of single cells

Inventors: Jered Haun (Irvine, CA); Xiaolong Qiu (Irvine, CA); Marissa Noelani Pennell (Rocklin, CA); Elliott E. Hui (South Pasadena, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
F04B43/04B01D63/005B01D63/088B01L3/502761B01D2319/025B01D2325/0283B01L2200/027B01L2200/0652B01L2300/0681B01L2300/0816B01L2300/0864
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,292,046
App. No.
17/058,634
Granted
May 6, 2025
Kind
B2
Abstract

A microfluidic tissue dissociation and filtration device simultaneously filters large tissue fragments and dissociates smaller aggregates into single cells, thereby improving single cell yield and purity. The device includes an inlet coupled to a first microfluidic channel at an upstream location and a first outlet at a downstream location. A first filter membrane is interposed between the first microfluidic channel and a second microfluidic channel, wherein the second microfluidic channel is in fluidic communication with the first microfluidic channel via the first filter membrane. The first filter membrane operates under a tangential flow format. A second outlet is coupled to a downstream location of the second microfluidic channel and includes a second filter membrane interposed between the second outlet and the second microfluidic channel. The dual membrane device increased single cell numbers by at least 3-fold for different tissue types.

Claims (17)

1. A microfluidic tissue dissociation and filtration device comprising:

an inlet coupled to a first microfluidic channel at an upstream location, the first microfluidic channel coupled to a first outlet at a downstream location, wherein the first microfluidic channel is disposed in a first layer of the microfluidic tissue dissociation and filtration device;

a second microfluidic channel located within a second layer of the microfluidic tissue dissociation and filtration device;

a first filter membrane interposed between the first microfluidic channel and the second microfluidic channel, wherein the second microfluidic channel is in fluidic communication with the first microfluidic channel by a first connecting fluid passageway containing the first filter membrane;

a second outlet coupled to a downstream location of the second microfluidic channel;

a second filter membrane interposed between the second outlet and the second microfluidic channel and contained in a second connecting fluid passageway that fluidically connects the second microfluidic channel to the second outlet;

a pump connected to a source of tissue or cellular aggregates contained within a fluid, the pump further fluidically connected to the inlet; and

wherein the first filter membrane comprises pores having diameters of d 1 and wherein the second filter membrane comprises pores having diameters of d 2 , wherein d 1 >d 2 and wherein the first filter membrane has pore diameters that are at least two times the pore diameters of the second filter membrane, and wherein the second filter membrane is configured to allow passage of single cells and fluid and generates an increase in yield of single cells from the tissue or cell aggregates of at least 3-fold in the second outlet.

2. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the first filter membrane has pore diameters greater than 15 μm and less than 1,000 μm and the second filter membrane has pore diameters greater than 5 μm and less than or equal to 100 μm.

3. The microfluidic tissue dissociation and filtration device of claim 2 , wherein the first connecting fluid passageway is formed in a third or more additional layers.

4. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the first filter membrane and the second filter membrane comprise a single layer of woven mesh polymer thread.

5. The microfluidic tissue dissociation and filtration device of claim 4 , wherein the first filter membrane and the second filter membrane are formed from a polyamide thread.

6. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the first connecting fluid passageway comprises a via, hole, or aperture that extends between the first microfluidic channel and the second microfluidic channel.

7. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the second connecting fluid passageway comprises a via, hole, or aperture that extends between the second microfluidic channel and the second outlet.

8. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the first filter membrane and the second filter membrane respectively comprise a single layer of woven mesh that is interposed between the first and second layers of the microfluidic tissue dissociation and filtration device.

9. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the pore diameters of the second filter membrane are between 10-20 μm and the first filter membrane has pore diameters that are between 2-3 times larger than the pore diameters of the second filter membrane.

10. The microfluidic tissue dissociation and filtration device of claim 1 , wherein the second filter membrane generates an increase in yield of single cells from the tissue or cell aggregates of at least 10-fold in the second outlet.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2020
From: HAUN, JERED; QIU, XIAOLONG; PENNELL, MARISSA NOELANI; HUI, ELLIOT E.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 054464/0418 →
Continuity (2)
Provisional Application 62678171 · May 30, 2018
Related Publication 20210205810A1 · Jul 8, 2021
References Cited (53)
US 9580678B2 · Haun et al. · 2017 [cited by applicant]
US 10722540B1 · Haun et al. · 2020 [cited by applicant]
US 20040051154A1 · Yamakawa · 2004 [cited by examiner]
US 20040259177A1 · Lowery et al. · 2004 [cited by applicant]
US 20110008397A1 · Cohen · 2011 [cited by applicant]
US 20110151479A1 · Stevens · 2011 [cited by examiner]
US 20140377866A1 · Haun et al. · 2014 [cited by applicant]
US 20150118728A1 · Rahman · 2015 [cited by examiner]
US 20150165346A1 · Puleo et al. · 2015 [cited by applicant]
US 20160310940A1 · Rajagopal · 2016 [cited by examiner]
US 20170131187A1 · Haun et al. · 2017 [cited by applicant]
US 20170145053A1 · Brellisford et al. · 2017 [cited by applicant]
US 20180015423A1 · Kim et al. · 2018 [cited by applicant]
US 20180361382A1 · Zobi et al. · 2018 [cited by applicant]
US 20190070605A1 · Haun et al. · 2019 [cited by applicant]
EP 3070160A1 · 2016 [cited by applicant]
JP 2007501633 · 2007 [cited by applicant]
JP 2012501245A · 2012 [cited by applicant]
JP 2014113064 · 2014 [cited by applicant]
JP 2015012839A · 2015 [cited by applicant]
JP 2016052300 · 2016 [cited by applicant]
JP 2016195589 · 2016 [cited by applicant]
KR 20120042531A · 2012 [cited by applicant]
WO WO2004101753A2 · 2004 [cited by applicant]
WO WO2010027955A2 · 2010 [cited by applicant]
WO 2018003476A1 · 2018 [cited by applicant]
WO WO2018189040 · 2018 [cited by applicant]
Response to Notice of Rejection dated Jul. 18, 2023 for Japanese Patent Application No. 2020-566610, English Translation for Amended Claims only (10 pages). [cited by applicant]
The extended European search report dated Jun. 28, 2021, for European Patent Application No. 19811784.8-1004, Applicant: The Regents of the University of California, (9 pages). [cited by applicant]
Communication pursuant to Rules 70(2) and 70a(2) EPC dated Jul. 15, 2021, for European Patent Application No. 19811784.8-1004, Applicant: The Regents of the University of California, (1 page). [cited by applicant]
Hattersley, S.M. et al., Development of a microfluidic device for the maintenance and interrogation of viable tissue biopsies, Lab Chip, 2008, 8, 1842-1846. [cited by applicant]
Zheng, S. et al., Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells, Journal of Chromatography A, 1162 (2007) 154-161. [cited by applicant]
Fan, X. et al., A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells, Biosensors and Bioelectronics 71 (2015) 380-386. [cited by applicant]
Response to the extended European search report dated Apr. 25, 2022, for European Patent Application No. 19811784.8-1004, Applicant: The Regents of the University of California, (63 pages). [cited by applicant]
PCT International Search Report and Written Opinion for PCT/US2019/034470, Applicant: The Regents of the University of California, dated Aug. 19, 2019 (8 pages). [cited by applicant]
Sarioglu, A.F. et al., A microfluidic device for label-free, physical capture of circulating tumor cell-clusters, Nat Methods. Jul. 2015 ; 12(7): 685-691. doi:10.1038/nmeth.3404. [cited by applicant]
Coumans, F.A.W. et al., Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood, PLoS ONE 8(4): e61774. doi:10.1371/journal.pone.0061774 (Apr. 2013). [cited by applicant]
Didar, T. F. etal., Separation of rare oligodendrocyte progenitor cells from brain using a high-throughput multilayer thermoplastic-based microfluidic device, Biomaterials 34 (2013) 5588e5593. [cited by applicant]
Krebs, M.G. et al., Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches, Journal of Thoracic Oncology | vol. 7, No. 2, Feb. 2012. [cited by applicant]
Lin, C-H et al., Single-Cell Enzyme-Free Dissociation of Neurospheres Using a Microfluidic Chip, dx.doi.org/10.1021/402724b, Anal. Chem. 2013, 85, 11920-11928. [cited by applicant]
Zhout, M-D. et al., Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells, Scientific Reports, (2014) 4:7392, DOI: 10.1038/srep07392. [cited by applicant]
Qiu, X. et al., Microfluidic device for mechanical dissociation of cancer cell aggregates into single cells, Lab Chip. Jan. 7, 2015; 15(1): 339-350. doi:10.1039/c4lc01126k. [cited by applicant]
Qiu, X. et al., Microfluidic channel optimization to improve hydrodynamic dissociation of cell aggregates and tissue, Scientific Reports, (2018) 8:2774, DOI:10.1038/s41598-018-20931-y. [cited by applicant]
Qiu, X. et al., Microfluidic device for rapid digestion of tissues into cellular suspensions, Lab Chip. Sep. 26, 2017; 17(19): 3300-3309. doi: 10.1039/c7lc00575j. [cited by applicant]
Vona, G. et al., Isolation by Size of Epithelial Tumor Cells A New Method for the Immunomorphological and Molecular Characterization of Circulating Tumor Cells, American Journal of Pathology, vol. 156, No. 1, Jan. 2000. [cited by applicant]
Wallman, L. et al., Biogrid—a microfluidic device for large-scale enzyme-free dissociation of stem cell aggregates, Lab Chip, 2011, 11, 3241. [cited by applicant]
Kang, Y-T. et al., Label-free Rapid Viable Enrichment of Circulating Tumor Cell by Photosensitive Polymer-based Microfilter Device, Theranostics, 2017; 7(13): 3179-3191. doi: 10.7150/thno. 19686. [cited by applicant]
Response to Office Action dated Nov. 29, 2023 for Japanese Patent Application No. 2020-566610; English Translations for Claims only; (7 pages). [cited by applicant]
Notice of Allowance dated Feb. 1, 2024, for Japanese Patent Application No. 2020-566610; (8 pages). [cited by applicant]
Communication under Rule 71(3) EPC dated Dec. 18, 2023, for European Patent Application No. 19811784.8-1004, (84 pages). [cited by applicant]
Communication under Rule 71(3) EPC dated Dec. 8, 2023, for European Patent Application No. 19811784.8-1004, (84 pages). [cited by applicant]
Reply to the communication about intention to grant a European patent under Rule 71(3) EPC dated Apr. 8, 2024, for European Patent Application No. 19811784.8-1004, (8 pages). [cited by applicant]
Decision to grant a European patent pursuant to Article 97(1) EPC dated Apr. 18, 2024, for European Patent Application No. 19811784.8-1004, (2 pages). [cited by applicant]